secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACTUATE THERAPEUTICS, INC. (ACTU)
CIK:        0001652935
Form:       8-K
Filed at:   2026-10-30T20:05:24+00:00
Accession:  0001683168-26-008193
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Actuate Therapeutics gets Nasdaq minimum bid price notice; 180 days to April 26, 2027 to regain $1.00
--------------------------------------------------------------------------------

- Nasdaq notice dated Oct 28, 2026: ACTU closing bid stayed below $1.00 for 30 consecutive business days, breaching Rule 5450(a)(1).
- Compliance window runs 180 calendar days to April 26, 2027; requires 10 straight closes at $1.00 or more plus meeting other Global Market standards.
- Common stock continues trading on the Nasdaq Global Market under ACTU; the notice has no immediate effect on listing.
- Separate July 15, 2026 MVLS deficiency notice gives until January 11, 2027; a second 180-day bid-price period would require moving to the Nasdaq Capital Market.
- Company says it is monitoring its bid price and weighing options, with no assurance it regains compliance or avoids delisting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1652935/000168316826008193/0001683168-26-008193-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1652935/000168316826008193/actuate_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-26-008193

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer